KMCSHILK M C Speciality Hospitals (India) Limited
Healthcare · Medical Care Facilities · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
KMC Speciality Hospitals (India) Limited provides medical and healthcare services in India. The company offers healthcare services in the areas of anesthesiology, breast clinic, cardiology, critical care, dermatology, dental maxillofacial, diabetology, emergency & urgent care, endocrinology, family clinic, fertility centre, general surgery, general medicine, geriatrics, gastroenterology, interventional radiology, infectious diseases, laboratory services, lung centre, liver disease, neurology, and nephrology and urology science, as well as ENT, head, and neck surgery; and kidney, liver, and bone marrow transplant. It also provides healthcare services in the areas of ophthalmology, obstetrics and gynecology, orthopaedics, oncology, paediatrics and neonatology, plastic surgery, psychiatry, pulmonology, rheumatology, spine surgery, transfusion medicine, vascular surgery. The company was formerly known as Seahorse Hospital Limited and changed its name to KMC Speciality Hospitals (India) Limited in October 2008. KMC Speciality Hospitals (India) Limited was incorporated in 1982 and is based in Trichy, India. KMC Speciality Hospitals (India) Limited is a subsidiary of Sri Kauvery Medical Care (India) Limited.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on KMCSHIL — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 37.9% YoY
- • Profit growth: 121.7% YoY
- • ROE: 22.2%
- • Trend strength (ADX): 30
- • Max drawdown (1y): 22%
- • Liquidity: ₹10.8 cr avg turnover
Bull case
- • Revenue growth: 37.9% YoY
- • Profit growth: 121.7% YoY
- • ROE: 22.2%
- • Trend strength (ADX): 30
Bear case
- • Promoter holding: 18.9%
- • Dividend yield: 0.00%
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • Momentum is fading versus the broader market
- • Promoter holding: 18.9%
- • Dividend yield: 0.00%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹10.27). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.